<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03032770</url>
  </required_header>
  <id_info>
    <org_study_id>USPA</org_study_id>
    <nct_id>NCT03032770</nct_id>
  </id_info>
  <brief_title>Early Prediction of Placenta Accreta by Ultrasound and Color Doppler</brief_title>
  <official_title>Early Prediction of Placenta Accreta by 2 Dimensional Transvaginal Ultrasound and Color Doppler</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Placenta accreta is a substantially life threatening condition and one of the causes of
      maternal morbidity and mortality in the world. According to study done in United Kingdom, The
      estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities
      overall and 577 per 10,000 in women with both a previous cesarean delivery and placenta
      previa. in a tertiary south Italian center, The incidence increased from 0.12% during the
      1970s, to 0.31% during the 2000s.While in United States of America, the prevalence of
      placenta accreta was 3.7 per 1000 deliveries.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Confirmation of occurrence of placenta accreta during delivery.</measure>
    <time_frame>duration of pregnancy</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">148</enrollment>
  <condition>Placenta Accreta</condition>
  <arm_group>
    <arm_group_label>placenta accreta</arm_group_label>
    <description>Having at least one sign suggestive of placenta accreta</description>
  </arm_group>
  <arm_group>
    <arm_group_label>normal placenta</arm_group_label>
    <description>Never having any of the signs suggestive of placenta accreta</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>two-dimensional ultrasound and color Doppler</intervention_name>
    <description>the eligible participants will be searched for signs suggestive of placenta accreta; low implantation of the gestational sac (&lt;4cm from the external os), presence of placental lakes, Disruption of placental-myometrial interface and trophoblast overlapping a uterine scar by 2 dimensional transvaginal ultrasound and Intraplacental dilated vessels, turbulent blood flows and greatly increased periplacental vascularity by Doppler ultrasound by level II sonographer and co-investigator under his supervision using ultrasound device.</description>
    <arm_group_label>normal placenta</arm_group_label>
    <arm_group_label>placenta accreta</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        first trimester pregnancy between 11 weeks and 13 weeks.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Low implantation of the gestational sac (&lt;4 cm from external os) by transvaginal
             ultrasound

          2. Presence of placental lakes by transvaginal ultrasound

          3. Disruption of placental-myometrial interface by transvaginal ultrasound

          4. Trophoblast overlapping a uterine scar (Cesarean section, myomectomy) by transvaginal
             ultrasound

          5. Intraplacental dilated vessels by Doppler ultrasound

          6. Turbulent blood flows by Doppler ultrasound

          7. Greatly increased periplacental vascularity by Doppler ultrasound

        Exclusion Criteria:

        a) Cases far away from our hospital and expected to be lost to be followed. b) Pregnant
        women who will refuse to Participate

        -
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 24, 2017</study_first_submitted>
  <study_first_submitted_qc>January 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2017</study_first_posted>
  <last_update_submitted>May 11, 2020</last_update_submitted>
  <last_update_submitted_qc>May 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Abbas</investigator_full_name>
    <investigator_title>clinical professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Placenta Accreta</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

